Where would you find the world's most productive pipeline
of new drugs? Not in the pristine research institutes of big pharma companies, but
in unregulated labs in the back streets of Shanghai and other Asian cities.
China has become the
world's factory for the psychoactive substances known as 'legal highs', and its
output is prodigious: drug control agencies have identified more that 400 new products,
and the list is growing all the time.
They include
stimulants, sedatives and psychedelic agents designed to alter mood or
consciousness. Legal highs have been
available in 'head shops' on the streets of most UK cities, but this does not
mean they are safe. The synthetic cannabinoid
Spice can cause seizures,
paranoid delusions and psychosis, and the Centre for Social Justice recorded 97
deaths from legal highs in the UK in 2012.
So from May 2016, the Psychoactive Substances Act made
it illegal to produce or supply legal highs in the UK. But yesterday, a landmark
court decision called the legislation into question, as many of the products
are approved for medical use. These include the anaesthetic nitrous oxide, or
laughing gas.
N2O has been used as a recreational drug since
1799, when 'laughing gas parties' were popular among the ruling classes. It has
now made a comeback at raves and music festivals (where discarded silver
canisters are a common sight) and among students, possibly to numb the pain of
tuition fees. The gas is widely obtainable because it is used by the food
industry to aerate whipped cream. This could explain the popularity of Bake Off
and the reason so many Brits seem addicted to cake.
Anyone who has experienced the benefits of nitrous
oxide in dentistry or childbirth will confirm what a powerful euphoric effect
it has. I once found myself walking out of the dentist laughing out loud after
paying a thousand pounds for root canal work. And after inhaling a lungful of
Entonox, my wife just chuckled when the obstetrician said she needed an
episiotomy.
People who use legal highs may be in it for the shits
and giggles, but they are unwittingly taking part in the world's largest
(uncontrolled) clinical trial. The labs who produce these designer drugs are
using their customers as guinea pigs in a real-life game of molecular roulette,
where the user takes all the risks. A small variation in chemical structure or manufacturing
processes can produce entirely different and unpredictable psychoactive
effects.
Aside from the latest ruling, there are many blurred
lines between legal and illegal drugs. There is a huge amount of off-label use
of licensed medicines by medically qualified prescribers. There are also many
agents that have crossed the line from illegal to legal use, such as cannabinoids
for MS, as well as previously approved medicines that have now been outlawed.
Our agency was responsible for the EU launch of
OxyContin and the first sublingual formulation of fentanyl, a powerful opioid
that is abused by many drug addicts. So we are acutely aware of the devastation
caused by the opioid epidemic in the US, and the criticism aimed at Purdue, the
maker of OxyContin.
We have also worked on ketamine (known on the street
as Special K) and a range of painkillers, hypnotics and antidepressants that
have addictive properties or potential for abuse. We have also pitched for
agents designed to treat opioid overdose and alcohol abuse.
We all belong to an ethical industry and have a
responsibility not just to adhere to regulations, but to consider the impact
our products have on people who misuse them. It's incumbent on us to do all we
can to ensure that are used appropriately, and that all stakeholders are aware
of the safety issues relating to them.
Drug abuse is a massive medical and social problem in
the UK, and it has been compounded by the availability of new psychoactive
agents virtually everywhere. People who go to prison for innocuous crimes and
in good health are often released with a Spice habit and in debt to criminal
gangs.
Banning legal highs had been criticised by many groups
because 'head shops' were replaced by criminal street dealers, and drugs could
be ordered like a takeaway using smartphones and social media. The recent court
case leaves the issue in limbo, but it may also present an opportunity to
rethink our national policy towards drug use and misuse. Every day we are
reminded of the power - medical, social and political - of the substances we
deal with.
© 2017 Life Healthcare Communications
www.life-healthcare.com